DK1446733T3 - Glycosylphosphatidylinositol indeholdende polypeptider - Google Patents
Glycosylphosphatidylinositol indeholdende polypeptiderInfo
- Publication number
- DK1446733T3 DK1446733T3 DK02801405T DK02801405T DK1446733T3 DK 1446733 T3 DK1446733 T3 DK 1446733T3 DK 02801405 T DK02801405 T DK 02801405T DK 02801405 T DK02801405 T DK 02801405T DK 1446733 T3 DK1446733 T3 DK 1446733T3
- Authority
- DK
- Denmark
- Prior art keywords
- polypeptides
- glycosylphosphatidylinositol
- containing polypeptides
- relates
- domain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Transplantation (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0124620A GB2380735A (en) | 2001-10-13 | 2001-10-13 | GPI-anchored proteins |
GB0200904A GB0200904D0 (en) | 2002-01-16 | 2002-01-16 | Anchors-2 |
GB0218889A GB0218889D0 (en) | 2002-08-14 | 2002-08-14 | Anchors 3 |
PCT/GB2002/004665 WO2003034275A2 (en) | 2001-10-13 | 2002-10-11 | Chimeric glycosylphosphatidylinositol containing peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1446733T3 true DK1446733T3 (da) | 2009-10-26 |
Family
ID=27256298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02801405T DK1446733T3 (da) | 2001-10-13 | 2002-10-11 | Glycosylphosphatidylinositol indeholdende polypeptider |
Country Status (17)
Country | Link |
---|---|
US (1) | US7485713B2 (da) |
EP (1) | EP1446733B1 (da) |
JP (1) | JP4384492B2 (da) |
KR (2) | KR20100039911A (da) |
CN (1) | CN1568330A (da) |
AT (1) | ATE442444T1 (da) |
AU (1) | AU2002334161B2 (da) |
CA (1) | CA2494706A1 (da) |
DE (1) | DE60233674D1 (da) |
DK (1) | DK1446733T3 (da) |
ES (1) | ES2329228T3 (da) |
HU (1) | HUP0401611A3 (da) |
IL (1) | IL161296A0 (da) |
NZ (1) | NZ532460A (da) |
PL (1) | PL369953A1 (da) |
PT (1) | PT1446733E (da) |
WO (1) | WO2003034275A2 (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006304387A1 (en) | 2005-10-14 | 2007-04-26 | Medimmune, Llc | Cell display of antibody libraries |
PT2532681E (pt) * | 2005-12-20 | 2014-12-23 | Sbi Biotech Co Ltd | Anticorpos anti-ilt7 |
WO2007098547A1 (en) * | 2006-03-01 | 2007-09-07 | Apollo Life Sciences Limited | A molecule and chimeric molecules thereof |
GB0618082D0 (en) * | 2006-09-14 | 2006-10-25 | Asterion Ltd | Growth factor |
EP2068914A4 (en) * | 2007-02-09 | 2011-07-20 | Medimmune Llc | PRESENTATION OF ANTIBODY BANK BY PLASMA MEMBRANES OF YEAST CELLS |
CN103694337B (zh) * | 2008-02-08 | 2016-03-02 | Ambrx公司 | 经修饰瘦素多肽和其用途 |
US11274139B2 (en) | 2013-04-12 | 2022-03-15 | Evox Therapeutics Ltd | Therapeutic delivery vesicles |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5374548A (en) * | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
US4857637A (en) * | 1986-05-07 | 1989-08-15 | Genentech, Inc. | Methods and compositions for immunologically modulating growth hormone receptor activity |
US5057417A (en) * | 1987-06-12 | 1991-10-15 | Genentech, Inc. | Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein |
US6113917A (en) * | 1995-04-25 | 2000-09-05 | Rmf Dictagene S.A. | Modified polypeptides for enhanced immunogenicity |
TW562807B (en) | 1997-04-01 | 2003-11-21 | Chugai Pharmaceutical Co Ltd | Novel secretory membrane protein |
EP1001990A4 (en) | 1997-06-26 | 2001-12-19 | Immunex Corp | PROTEIN BINDING TO TRAIL PROTEIN |
WO1999060113A1 (fr) * | 1998-05-20 | 1999-11-25 | Chugai Seiyaku Kabushiki Kaisha | Nouveau procede d'isolation de gene |
EP1171579A4 (en) | 1999-03-24 | 2002-07-31 | Human Genome Sciences Inc | TR9 HUMAN RECEPTOR OF TUMOR NECROSIS FACTORS |
JP3815409B2 (ja) * | 2002-08-29 | 2006-08-30 | ブラザー工業株式会社 | 電話端末、通話システムおよび端末制御プログラム |
-
2002
- 2002-10-11 US US10/492,403 patent/US7485713B2/en not_active Expired - Fee Related
- 2002-10-11 JP JP2003536934A patent/JP4384492B2/ja not_active Expired - Lifetime
- 2002-10-11 WO PCT/GB2002/004665 patent/WO2003034275A2/en active Application Filing
- 2002-10-11 NZ NZ532460A patent/NZ532460A/en not_active IP Right Cessation
- 2002-10-11 KR KR1020107007082A patent/KR20100039911A/ko not_active Application Discontinuation
- 2002-10-11 PT PT02801405T patent/PT1446733E/pt unknown
- 2002-10-11 HU HU0401611A patent/HUP0401611A3/hu unknown
- 2002-10-11 DE DE60233674T patent/DE60233674D1/de not_active Expired - Lifetime
- 2002-10-11 AU AU2002334161A patent/AU2002334161B2/en not_active Ceased
- 2002-10-11 EP EP02801405A patent/EP1446733B1/en not_active Expired - Lifetime
- 2002-10-11 DK DK02801405T patent/DK1446733T3/da active
- 2002-10-11 CN CNA028202775A patent/CN1568330A/zh active Pending
- 2002-10-11 KR KR1020047005419A patent/KR20050035511A/ko active IP Right Grant
- 2002-10-11 ES ES02801405T patent/ES2329228T3/es not_active Expired - Lifetime
- 2002-10-11 IL IL16129602A patent/IL161296A0/xx not_active IP Right Cessation
- 2002-10-11 AT AT02801405T patent/ATE442444T1/de not_active IP Right Cessation
- 2002-10-11 PL PL02369953A patent/PL369953A1/xx unknown
- 2002-10-11 CA CA002494706A patent/CA2494706A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PT1446733E (pt) | 2009-09-28 |
DE60233674D1 (de) | 2009-10-22 |
JP2005505307A (ja) | 2005-02-24 |
US20050059577A1 (en) | 2005-03-17 |
US7485713B2 (en) | 2009-02-03 |
JP4384492B2 (ja) | 2009-12-16 |
HUP0401611A3 (en) | 2010-01-28 |
CA2494706A1 (en) | 2003-04-24 |
HUP0401611A2 (hu) | 2004-11-29 |
ES2329228T3 (es) | 2009-11-24 |
AU2002334161B2 (en) | 2007-03-29 |
IL161296A0 (en) | 2004-09-27 |
KR20100039911A (ko) | 2010-04-16 |
PL369953A1 (en) | 2005-05-02 |
NZ532460A (en) | 2005-10-28 |
EP1446733B1 (en) | 2009-09-09 |
KR20050035511A (ko) | 2005-04-18 |
WO2003034275A2 (en) | 2003-04-24 |
WO2003034275A3 (en) | 2003-11-27 |
EP1446733A2 (en) | 2004-08-18 |
CN1568330A (zh) | 2005-01-19 |
ATE442444T1 (de) | 2009-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU19903A (sh) | Novi receptor nukleinskih kiselina i polipeptida | |
CY1112101T1 (el) | Νευροτροφικοι παραγοντες | |
WO2005005462A3 (en) | Blys antagonists and uses thereof | |
TR200102191T2 (tr) | HER-2/neu füzyon proteinleri. | |
SE0101675D0 (sv) | Novel composition | |
WO2002089738A3 (en) | Proteomimetic compounds and methods | |
DK1229047T3 (da) | IL-1-receptor-fusionsproteiner anvendt som antagonister og fremgangsmåder til fremstilling og anvendelse | |
CY1111750T1 (el) | Νευροτροφικοι παραγοντες | |
DE69933696D1 (de) | Cytokinrezeptor-kette | |
DK1446733T3 (da) | Glycosylphosphatidylinositol indeholdende polypeptider | |
ATE390482T1 (de) | Interleukin-1 hy2. mittel und verfahren | |
TW200508246A (en) | Anti-dengue virus antibodies, compositions, methods and uses | |
DE60133366D1 (de) | Irak-4 zusammensetzungen und deren verwendungen | |
DK0793721T3 (da) | Peptider, der er i stand til at binde sig til GAP-proteinets SH3-domæne, nukleotidsekvenser, der koder derfor, fremstilling og anvendelse deraf | |
ATE247130T1 (de) | Inhibitoren für den urokinaserezeptor | |
TR200102655T2 (tr) | Dört L. infantum proteininin antijen belirleyicilerini kodlayan kimerik gen. | |
AR022150A1 (es) | Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados | |
IL162601A0 (en) | Raf/ras binding proteins, their preparation and use | |
CY1109904T1 (el) | Προαγωγεας της il-18bp, η παρασκευη και χρηση του | |
SG148195A1 (en) | Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof | |
BRPI0418335A (pt) | ácido nucléico codificando uma proteìna de receptor de postaglandina e métodos de uso desta | |
DE50206254D1 (de) | Pna-konjugat zur therapie der chronischen myeloischen leukämie (cml) | |
WO2005046577A3 (en) | Human prostaglandin ep1 receptor variants and methods of using same | |
DE60031262D1 (de) | Menschliche promotoren des gaba b-rezeptors 1 |